Clinical Trial

Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this clinical study is to evaluate the effectiveness and safety of a dermocosmetic product in reducing facial redness and visible blood vessels associated with erythematotelangiectatic rosacea. Investigators will compare the dermocosmetic product to a placebo applied to opposite sides of the face, when used alone and in combination with laser treatment. Participants will apply the products twice daily for 2 month followed by continued use in combination with laser treatment, and will attend regular clinical visits for assessments and questionnaires.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-07-08
Trial Details
NCT Number NCT07521462
Lead Sponsor ISISPHARMA
Conditions Rosacea, Erythematotelangiectatic, Rosacea Subtype 1 (Erythematotelangiectatic)
Enrollment 50 participants
Start Date 2026-09-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-07